A troublesome burden, the amplification of EGFR in glioblastoma!

Neuro Oncol. 2020 May 15;22(5):594-595. doi: 10.1093/neuonc/noaa055.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Brain Neoplasms*
  • ErbB Receptors
  • Glioblastoma*
  • Humans
  • Lomustine
  • Temozolomide

Substances

  • Antibodies, Monoclonal, Humanized
  • Lomustine
  • EGFR protein, human
  • ErbB Receptors
  • depatuxizumab mafodotin
  • Temozolomide